We are live on ! Find out more
MC

Merck & Co Portfolio holdings

AUM $349M
1-Year Est. Return 146.07%
This Fund
S&P 500
This Quarter Est. Return
+10.33%
1 Year Est. Return
+146.07%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$228M
AUM Growth
+$12.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
99.76%
Holding
13
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSNL icon
1
Personalis
PSNL
$1.39B
$91.6M 40.16%
14,044,943
– –
MRNA icon
2
Moderna
MRNA
$21.5B
$59.6M 26.15%
2,308,190
– –
KYMR icon
3
Kymera Therapeutics
KYMR
$8.75B
$43.7M 19.17%
772,165
– –
ALEC icon
4
Alector
ALEC
$203M
$10.5M 4.6%
3,545,719
– –
TRDA icon
5
Entrada Therapeutics
TRDA
$267M
$10.1M 4.43%
1,739,768
– –
EVAX
6
Evaxion A/S
EVAX
$25M
$4.57M 2%
1,214,126
– –
STRO icon
7
Sutro Biopharma
STRO
$400M
$2.37M 1.04%
272,351
– –
VRDN icon
8
Viridian Therapeutics
VRDN
$2.49B
$2.02M 0.88%
93,414
– –
LVTX
9
DELISTED
LAVA Therapeutics
LVTX
$1.79M 0.79%
1,149,345
– –
XLO icon
10
Xilio Therapeutics
XLO
$61M
$1.25M 0.55%
105,983
– –
CARM
11
DELISTED
Carisma Therapeutics
CARM
$404K 0.18%
1,473,240
– –
NEUP
12
Neuphoria Therapeutics
NEUP
$21.1M
$118K 0.05%
10,027
– –
HURA
13
TuHURA Biosciences
HURA
$135M
$34.6K 0.02%
13,950
– –

Similar funds

KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
EPW
Endeavor Private Wealth Topeka, Kansas $349M AUM 16.45% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
1CP
11 Capital Partners Darien, Connecticut $348M AUM 19.84% 1-Year Est. Return
SMC
Spider Management Company Richmond, Virginia $351M AUM 18.35% 1-Year Est. Return
AWA
Argos Wealth Advisors Sacramento, California $348M AUM

Merck & Co's Q3 2025 Portfolio in Review

As of Q3 2025, Merck & Co held 13 positions worth $228M, up 5.8% from $216M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 0%. Merck & Co opened no new positions and made no exits, leaving the 13-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Merck & Co's ten largest holdings make up 100% of its $228M portfolio in Q3 2025.
  • Merck & Co opened 0 new positions and closed 0 in Q3 2025.
  • Merck & Co's portfolio value rose 5.8% quarter-over-quarter to $228M.

Based on Merck & Co's 13F filing for Q3 2025, filed 12 Nov 2025.